Roles of Growth Hormone–Dependent JAK-STAT5 and Lyn Kinase Signaling in Determining Lifespan and Cancer Incidence
Endocrinology · 2024
DOI: 10.1210/endocr/bqae136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2024. Verfasst von Yash Chhabra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Bioscience, University of Queensland, St Lucia 4069, Australia. Hauptthemen laut MEDLINE: Growth Hormone, Janus Kinase 2, Longevity, Signal Transduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHMRC.
Abstract (Originalsprache)
In rodents, loss of growth hormone (GH) or its receptor is associated with extended lifespan. We aimed to determine the signaling process resulting in this longevity using GH receptor (GHR)-mutant mice with key signaling pathways deleted and correlate this with cancer incidence and expression of genes associated with longevity. GHR uses both canonical janus kinase (JAK)2-signal transducer and activator of transcription (STAT) signaling as well as signaling via the LYN-ERK1/2 pathway. We used C57BL/6 mice with loss of key receptor tyrosines and truncation resulting in 1) loss of most STAT5 response to GH; 2) total inability to generate STAT5 to GH; 3) loss of Box1 to prevent activation of JAK2 but not LYN kinase; or 4) total knockout of the receptor. For each mutant we analyzed lifespan, histopathology to determine likely cause of death, and hepatic gene and protein expression. The extended lifespan is evident in the Box1-mutant males (retains Lyn activation), which have a median lifespan of 1016 days compared to 890 days for the Ghr−/− males. In the females, GhrBox1−/− mice have a median lifespan of 970 days compared to 911 days for the knockout females. Sexually dimorphic GHR-STAT5 is repressive for longevity, since its removal results in a median lifespan of 1003 days in females compared to 734 days for wild-type females. Numerous transcripts related to insulin sensitivity, oxidative stress response, and mitochondrial function are regulated by GHR-STAT5; however, LYN-responsive genes involve DNA repair, cell cycle control, and anti-inflammatory response. There appears to be a yin-yang relationship between JAK2 and LYN that determines lifespan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Molecular Bioscience, University of Queensland, St Lucia 4069, Australia.
- Faculty of Medicine, Frazer Institute, The University of Queensland, Woolloongabba, QLD 4102, Australia.
- Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
- School of Chemistry & Molecular Biosciences, University of Queensland, St Lucia 4069, Australia.
ORCID-Profile: Yash Chhabra, Andrew James Brooks
Förderung
- NHMRC
Zitieren
APA
Chhabra, Y., Bielefeldt-Ohmann, H., Brooks, T. L., Brooks, A. J., & Waters, M. J. (2024). Roles of Growth Hormone–Dependent JAK-STAT5 and Lyn Kinase Signaling in Determining Lifespan and Cancer Incidence. Endocrinology. https://doi.org/10.1210/endocr/bqae136
Vancouver
Chhabra Y, Bielefeldt-Ohmann H, Brooks TL, Brooks AJ, Waters MJ. Roles of Growth Hormone–Dependent JAK-STAT5 and Lyn Kinase Signaling in Determining Lifespan and Cancer Incidence. Endocrinology. 2024. doi:10.1210/endocr/bqae136
BibTeX
@article{Chhabra2024,
author = {Chhabra, Yash and Bielefeldt-Ohmann, Helle and Brooks, Tania Louise and Brooks, Andrew James and Waters, Michael J},
title = {Roles of Growth Hormone–Dependent JAK-STAT5 and Lyn Kinase Signaling in Determining Lifespan and Cancer Incidence},
journal = {Endocrinology},
year = {2024},
doi = {10.1210/endocr/bqae136}
}
EUVIMED